Home » Topics » BioWorld Science

BioWorld Science
RSS

Cyclic hexapeptide antifungal agents claimed by Lilly

Nov. 26, 1996

New antihypertensive agent from Calpis Food Industry

Nov. 26, 1996

Three additional approvals for Rilutek

Nov. 25, 1996

Milestone achieved in Millennium/Roche research collaboration

Nov. 25, 1996

Neose reports promising phase I results for novel antiulcer drug

Nov. 25, 1996

Nyotran progresses towards market introduction

Nov. 25, 1996

Glaxo Wellcome to take control of Japanese joint venture

Nov. 25, 1996

Research suggests improved treatment for anemia

Nov. 25, 1996

GBS vaccine proven safe and immunogenic

Nov. 25, 1996

P&U and PRIZM begin ophthalmological collaboration

Nov. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...